10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
14.04
+0.43 (3.16%)
At close: Dec 20, 2024, 4:00 PM
13.95
-0.09 (-0.64%)
After-hours: Dec 20, 2024, 4:20 PM EST
10x Genomics Market Cap
10x Genomics has a market cap or net worth of $1.70 billion as of December 20, 2024. Its market cap has decreased by -69.78% in one year.
Market Cap
1.70B
Enterprise Value
1.39B
1-Year Change
-69.78%
Ranking
Category
Stock Price
$14.04
Market Cap Chart
Since September 12, 2019, 10x Genomics's market cap has decreased from $4.95B to $1.70B, a decrease of -65.67%. That is a compound annual growth rate of -18.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 1.70B | -74.31% |
| Dec 29, 2023 | 6.61B | 58.59% |
| Dec 30, 2022 | 4.17B | -74.93% |
| Dec 31, 2021 | 16.64B | 9.21% |
| Dec 31, 2020 | 15.24B | 107.79% |
| Dec 31, 2019 | 7.33B | 48.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xencor | 1.68B |
| Dynavax Technologies | 1.68B |
| Integra LifeSciences Holdings | 1.68B |
| Fortrea Holdings | 1.66B |
| Arcutis Biotherapeutics | 1.65B |
| Clover Health Investments | 1.60B |
| Teladoc Health | 1.54B |
| RxSight | 1.54B |